跳至主要内容
临床试验/NCT04552444
NCT04552444Unknown不适用

Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
28-day mortality

研究概览

简要总结

Carbapenem resistance is a high mortality rate of Klebsiella pneumoniae infection. It has been proved that high-dose carbapenem can reduce mortality and has a certain clinical effect. In this study, a high dose of biapenem was compared to determine whether it had a similar effect than meropenem.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
14 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICU hospitalized for more than 3 days;
  • Biapenem used for more than 3 days

排除标准

  • Patients who refuse to be included in the group or pregnant women or under the age of 14 or ICU hospitalized for less than 3 days

研究组 & 干预措施

the death group

Through the corresponding treatment, the patients who died within 28 days

干预措施: Biapenem (Drug)

the survival group

Through the corresponding treatment, the patients who survived within 28 days

干预措施: Biapenem (Drug)

结局指标

主要结局

28-day mortality

时间窗: 2017.01.01-2021.12.31

次要结局

  • Clearance rate of pathogenic microorganisms(2017.01.01-2021.12.31)
  • ICU hospitalization days(2017.01.01-2021.12.31)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Man Huang, Ph.D

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

研究点 (1)

Loading locations...

相似试验